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Commentary to Accompany ‘Predictors of Outcome After Endovascular Repair for
Chronic type B Dissection’
Brian J. Manning*
Cork University Hospital, Cork, IrelandWhilst endovascular stent graft treatment is now well accepted
in themanagement of acute complicated Type B aortic dissection, its
role in the chronic complicated Type B dissection has been more
controversial. The thickened dissection membrane of the chronic
diseasehasbeenseenasabarrier to stentgraft deploymentaswell as
successful aortic remodelling. To date the evidence has been slow in
coming, and series combining acute and chronic dissections have
been of limited use in allowing for assessment of treatment efﬁcacy.
The publication byMani et al. is therefore an important addition
to the literature, as it is an analysis limited to aneurysms of chronic
dissections with treatment in most cases (49/58) in the elective
setting.
Technical success of initial treatment is not surprising. To date
clinical success for this disease has been more elusive and unpre-
dictable and at the present time, has usually only been conﬁrmed
during the course of follow-up. We know that without interven-
tion, the natural history for these patients is not good. In a series of
50 patients being followed-up for false lumen aneurysms of chronic
dissection (median initial diameter 4.7 cm), 10 underwent surgical
intervention and 9 of the remaining 40 patients died of fatal
rupture with a mean follow-up time of 40 months.1 The current
study of treated patients with larger initial aneurysm diameter
(mean 6.4 cm) and has a similar follow-up time (mean 38 months).
Of 55 patients only 2 had conﬁrmed aneurysm related mortality
following hospital discharge. Although there were a further 6
deaths of unknown cause the comparison is still favourable.
The data on aortic morphology during follow-up is impressive:
24/47 patients showed a reduction in size of the false lumen
aneurysm, and this was signiﬁcantly associated with survival
advantage. Although this indicates that the therapy is effective in at
least a signiﬁcant proportion of patients, the converse also applies;
for a sizeable subgroup the treatment does notwork aswell or at all.
Unlike infrarenal aortic aneurysms where a stable size post-EVAR is
acceptable as long as there is not an endoleak, a stable false lumen
aneurysm is not necessarily free from risk of rupture when there is
persistent false lumen ﬂow. (The authors acknowledge that absence
of enhancement on arterial phase CT does not necessarily imply
false lumen thrombosis). Although 8 of 12 patients with more
limited Type 3a dissections showed evidence of aortic remodellingDOI of original article: 10.1016/j.ejvs.2012.01.016.
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doi:10.1016/j.ejvs.2012.02.009only 16 of 35 patients who had follow-up imaging for the more
extensive Type 3bdissections showed evidence of a decrease in false
lumen diameter. For these patients the goal of covering the primary
entry tear may not be enough. We do not know if false lumen
pressure has been reduced, altered or eliminated, or if pathological
ﬂow patterns thought to lead to aneurysm progression have been
attenuated (or even created!). The presence of these unknowns, and
persistent false lumen perfusion and high re-intervention rates in
this and other series2,3 remind us of our incomplete understanding
of the pathophysiology of this disease and how it might be altered
by endovascular means. It is clear that one size does not ﬁt all, as
each dissection is unique with tears and re-entrys of varying sizes
and locations. Patients with more extensive dissections are more
likely to require extensive aortic coverage at the ﬁrst operation. The
challenge is to better deﬁne the treatment required based on pre-
operative analysis, to be able to predict favourable remodelling
after treatment even in more extensive dissections, and perhaps to
know which dissections are unlikely to be adequately treated by
current endovascular methods. Evolving MRI techniques4,5 may
allow us to elucidate the ﬂow dynamics in the false lumen that lead
to aneurysm progression. Understanding the speciﬁc ﬂow patterns
for each dissectionmayallow us to tailor the endovascular solutions
accordingly, and to conﬁrm that treatment has been successful
before the patient leaves hospital.References
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